EpiVax Therapeutics

0 followers

‌

EpiVax Therapeutics ("EVT"), founded in 2017, employs a world-leading technology, developed over 22 years by EpiVax, to design vaccines that aim to activate the body’s T cells to cure or prevent disease in the host.

Industries

Headquarters

Employees

Links

Org chart

Annie De Groot

CEO

Annie De Groot

Collapse

William Martin

Co-Founder, COO & CIO

Gary Steinberg

Chief Medical Officer

Guilhem Richard

Chief Scientific Officer / Chief Technology Officer

Gregory Covino

CFO

Dan Adams

Chairman And Acting CEO

Teams

Advisory Team

6 members

Leadership Team

3 members

Similar companies

Thermo Fisher Scientific

141 followers

Regeneron

88 followers

Vertex Pharmaceuticals

50 followers

Verily Life Sciences

36 followers

Alexion Pharmaceuticals

32 followers

PerkinElmer

8 followers

Merck

195 followers

AbbVie

149 followers

CytomX

3 followers

Aldevron

2 followers

Worldwide Clinical Trials

4 followers

Discover companies